» Articles » PMID: 32244839

Tunneling Nanotubes and Tumor Microtubes in Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2020 Apr 5
PMID 32244839
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Intercellular communication among cancer cells and their microenvironment is crucial to disease progression. The mechanisms by which communication occurs between distant cells in a tumor matrix remain poorly understood. In the last two decades, experimental evidence from different groups proved the existence of thin membranous tubes that interconnect cells, named tunneling nanotubes, tumor microtubes, cytonemes or membrane bridges. These highly dynamic membrane protrusions are conduits for direct cell-to-cell communication, particularly for intercellular signaling and transport of cellular cargo over long distances. Tunneling nanotubes and tumor microtubes may play an important role in the pathogenesis of cancer. They may contribute to the resistance of tumor cells against treatments such as surgery, radio- and chemotherapy. In this review, we present the current knowledge about the structure and function of tunneling nanotubes and tumor microtubes in cancer and discuss the therapeutic potential of membrane tubes in cancer treatment.

Citing Articles

Examination of germline and somatic intercellular bridges in reveals insights into the evolutionarily conserved mechanism of intercellular bridge formation.

Price K, Tharakan D, Salvenmoser W, Ayers K, Mah J, Dunn C bioRxiv. 2025; .

PMID: 40027827 PMC: 11870534. DOI: 10.1101/2025.02.19.639158.


Unveiling the power of mitochondrial transfer in cancer progression: a perspective in ovarian cancer.

Wang C, Xie C J Ovarian Res. 2024; 17(1):233.

PMID: 39580453 PMC: 11585251. DOI: 10.1186/s13048-024-01560-8.


Assembly of glioblastoma tumoroids and cerebral organoids: a 3D in vitro model for tumor cell invasion.

Kim J, Kim R, Lee W, Kim G, Jeon S, Lee Y Mol Oncol. 2024; 19(3):698-715.

PMID: 39473365 PMC: 11887666. DOI: 10.1002/1878-0261.13740.


Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible Strategy.

Alekseenko I, Zhukova L, Kondratyeva L, Buzdin A, Chernov I, Sverdlov E Int J Mol Sci. 2024; 25(19).

PMID: 39408784 PMC: 11476449. DOI: 10.3390/ijms251910454.


Chemoresistance and the tumor microenvironment: the critical role of cell-cell communication.

Wilczynski B, Dabrowska A, Kulbacka J, Baczynska D Cell Commun Signal. 2024; 22(1):486.

PMID: 39390572 PMC: 11468187. DOI: 10.1186/s12964-024-01857-7.


References
1.
Cairncross J, Wang M, Jenkins R, Shaw E, Giannini C, Brachman D . Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J Clin Oncol. 2014; 32(8):783-90. PMC: 3940537. DOI: 10.1200/JCO.2013.49.3726. View

2.
Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View

3.
Gurke S, Barroso J, Hodneland E, Bukoreshtliev N, Schlicker O, Gerdes H . Tunneling nanotube (TNT)-like structures facilitate a constitutive, actomyosin-dependent exchange of endocytic organelles between normal rat kidney cells. Exp Cell Res. 2008; 314(20):3669-83. DOI: 10.1016/j.yexcr.2008.08.022. View

4.
Dekker T, van de Velde C, van Pelt G, Kroep J, Julien J, Smit V . Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat. 2013; 139(2):371-9. DOI: 10.1007/s10549-013-2571-5. View

5.
Davis D, Sowinski S . Membrane nanotubes: dynamic long-distance connections between animal cells. Nat Rev Mol Cell Biol. 2008; 9(6):431-6. DOI: 10.1038/nrm2399. View